Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?

J Clin Microbiol. 2013 May;51(5):1596-9. doi: 10.1128/JCM.00472-13. Epub 2013 Feb 27.

Abstract

Patients may harbor both drug-susceptible and -resistant bacteria, representing heteroresistance. We studied mixtures of isoniazid-resistant and -susceptible Mycobacterium tuberculosis strains. Conventional drug susceptibility testing was the most sensitive method of detection, whereas the line probe assay and sequencing were not able to detect the clinically relevant 1% proportion of resistant bacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Antitubercular Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Base Sequence
  • Catalase / genetics
  • Drug Resistance, Bacterial / genetics*
  • Genotype
  • Humans
  • Isoniazid / pharmacology*
  • Isoniazid / therapeutic use
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Oxidoreductases / genetics
  • Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Tuberculosis, Multidrug-Resistant / drug therapy

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • Oxidoreductases
  • Catalase
  • katG protein, Mycobacterium tuberculosis
  • InhA protein, Mycobacterium
  • Isoniazid